Covered recipient · General Payments record
KATHERINE LICATA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021
$133.41
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $133.41 | 18 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $121.41 | 17 |
| ABBVIE INC. | $12.00 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $133.41 | 18 |
Payment records · PY2021 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $12.00 | 11/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794777103 | CMS |
| Novo Nordisk Inc | $2.82 | 04/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811203859 | CMS |
| Novo Nordisk Inc | $7.97 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810768995 | CMS |
| Novo Nordisk Inc | $3.84 | 06/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811429683 | CMS |
| Novo Nordisk Inc | $8.64 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811316701 | CMS |
| Novo Nordisk Inc | $9.52 | 06/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811429689 | CMS |
| Novo Nordisk Inc | $6.03 | 08/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811050439 | CMS |
| Novo Nordisk Inc | $9.53 | 09/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811316703 | CMS |
| Novo Nordisk Inc | $12.57 | 09/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810662817 | CMS |
| Novo Nordisk Inc | $8.46 | 09/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811544991 | CMS |
| Novo Nordisk Inc | $7.22 | 09/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811203865 | CMS |
| Novo Nordisk Inc | $12.50 | 10/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811203867 | CMS |
| Novo Nordisk Inc | $8.12 | 10/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810662821 | CMS |
| Novo Nordisk Inc | $0.06 | 11/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810769001 | CMS |
| Novo Nordisk Inc | $5.60 | 11/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811050447 | CMS |
| Novo Nordisk Inc | $4.59 | 11/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811316709 | CMS |
| Novo Nordisk Inc | $5.46 | 12/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811544997 | CMS |
| Novo Nordisk Inc | $8.48 | 12/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811316713 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.